Research Article

[Retracted] Efficacy of Bifidobacterium Triple Viable Enteric-Coated Capsules Combined with Enteral Nutrition on Patients with Chronic Critical Illness and Influence on Immune and Coagulation Function

Table 2

Comparison of APACHE II and SOFA scores between the two groups of patients.

GroupAPACHE II score (score)SOFA score (score)
Before treatmentAfter treatmentBefore treatmentAfter treatment

Control group (n = 50)20.15 ± 2.5814.21 ± 1.3610.52 ± 1.267.26 ± 0.84
Observation group (n = 51)20.01 ± 2.1810.08 ± 0.9510.43 ± 1.414.35 ± 1.21
t value0.30218.1240.34614.382
P value0.763<0.0010.729<0.001

Note. Compared with this group before treatment, .